Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential.

The surface chemistry of biomaterials can have a significant impact on their performance in biological applications. Our recent work suggests that cerium oxide nanoparticles are potent antioxidants in cell culture models and we have evaluated several therapeutic applications of these nanoparticles in different biological systems. Knowledge of protein adsorption and cellular uptake will be very useful in improving the beneficial effects of cerium oxide nanoparticles in biology. In the present study, we determined the effect of zeta potential of cerium oxide nanoparticles on adsorption of bovine serum albumin (BSA) and cellular uptake in adenocarcinoma lung cells (A549). The zeta potential of the nanoparticles was varied by dispersing them in various acidic and basic pH solutions. UV-visible spectroscopy and inductively coupled plasma mass spectrometry (ICP-MS) were used for the protein adsorption and cellular uptake studies, respectively. Nanoceria samples having positive zeta potential were found to adsorb more BSA while the samples with negative zeta potential showed little or no protein adsorption. The cellular uptake studies showed preferential uptake for the negatively charged nanoparticles. These results demonstrate that electrostatic interactions can play an important factor in protein adsorption and cellular uptake of nanoparticles.

[1]  Marek Kosmulski,et al.  The pH-dependent surface charging and the points of zero charge. , 2002, Journal of colloid and interface science.

[2]  Si-Shen Feng,et al.  PLGA/TPGS Nanoparticles for Controlled Release of Paclitaxel: Effects of the Emulsifier and Drug Loading Ratio , 2003, Pharmaceutical Research.

[3]  K. Hermansson,et al.  Strong and weak adsorption of CO on CeO2 surfaces from first principles calculations , 2004 .

[4]  M. Das,et al.  Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. , 2007, Biomaterials.

[5]  S. Seal,et al.  Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides , 2006, Nature nanotechnology.

[6]  Y. Tong,et al.  Selective adsorption behaviors of proteins on polypyrrole-based adsorbents , 2006 .

[7]  Si-Shen Feng,et al.  Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.

[8]  G. Whitesides,et al.  Effect of Surface Wettability on the Adsorption of Proteins and Detergents , 1998 .

[9]  Russell J Mumper,et al.  Microparticles and nanoparticles as delivery systems for DNA vaccines. , 2003, Critical reviews in therapeutic drug carrier systems.

[10]  Hongzhe Sun,et al.  Transferrin-mediated gold nanoparticle cellular uptake. , 2005, Bioconjugate chemistry.

[11]  G. Watson,et al.  Atomistic models for CeO(2)(111), (110), and (100) nanoparticles, supported on yttrium-stabilized zirconia. , 2002, Journal of the American Chemical Society.

[12]  S. Chan,et al.  Ceria nanoparticles: Size, size distribution, and shape , 2004 .

[13]  S. Seal,et al.  Cerium oxide nanoparticles increase the lifespan of cultured brain cells and protect against free radical and mechanical trauma , 2003 .

[14]  Robert N Grass,et al.  Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. , 2005, Environmental science & technology.

[15]  S. Seal,et al.  Synthesis of Nanocrystalline Ceria Particles for High Temperature Oxidation Resistant Coating , 2002 .

[16]  Robin A. J. Smith,et al.  Drug delivery to mitochondria: the key to mitochondrial medicine. , 2000, Advanced drug delivery reviews.

[17]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[18]  Jain Kk.  Nanodiagnostics: application of nanotechnology in molecular diagnostics , 2003 .

[19]  S. Feng,et al.  Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[20]  J. Bacri,et al.  Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. , 2003, Biomaterials.

[21]  Yu-Chi Wang,et al.  The sorption of lysozyme and ribonuclease onto ferromagnetic nickel powder 2. Desorption and competitive adsorption , 1995 .

[22]  W. Norde,et al.  The behavior of some model proteins at solid-liquid interfaces. 2. Sequential and competitive adsorption. , 1990 .

[23]  J L West,et al.  Applications of nanotechnology to biotechnology commentary. , 2000, Current opinion in biotechnology.

[24]  A. Zydney,et al.  Effect of solution pH on protein transport through ultrafiltration membranes , 1999, Biotechnology and bioengineering.

[25]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[26]  K. Landfester,et al.  Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. , 2006, Biomaterials.

[27]  Vladimir P Zharov,et al.  Self-assembling nanoclusters in living systems: application for integrated photothermal nanodiagnostics and nanotherapy. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[28]  L. Wallenberg,et al.  Crystallography and porosity effects of CO conversion on mesoporous CeO2 , 2004 .

[29]  Woo-Sik Kim,et al.  Separation of serum proteins with uncoupled microsphere particles in a stirred cell 1 Part of this p , 1998 .

[30]  S. Suen,et al.  Modification of porous alumina membranes with n-alkanoic acids and their application in protein adsorption , 2006 .

[31]  Naomi J Halas,et al.  Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. , 2003, Annual review of biomedical engineering.

[32]  K. Chittur,et al.  FTIR/ATR for protein adsorption to biomaterial surfaces. , 1998, Biomaterials.

[33]  Heather Kalish,et al.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. , 2003, Radiology.

[34]  A. Zydney,et al.  Protein adsorption in asymmetric ultrafiltration membranes with highly constricted pores , 1990 .

[35]  R. Tarnuzzer,et al.  Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. , 2005, Nano letters.

[36]  K. Jain,et al.  Nanodiagnostics: application of nanotechnology in molecular diagnostics , 2003, Expert review of molecular diagnostics.

[37]  Sema Salgın,et al.  Adsorption of bovine serum albumin on polyether sulfone ultrafiltration membranes: Determination of interfacial interaction energy and effective diffusion coefficient , 2006 .

[38]  R. Finley,et al.  Overview of targeted therapies for cancer. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[39]  David Farrar,et al.  Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. , 2006, Journal of the American Chemical Society.

[40]  F. Ding,et al.  Impacts of the surface charge property on protein adsorption on hydroxyapatite , 2002 .

[41]  Wen-Yih Chen,et al.  The sorption of lysozyme and ribonuclease onto ferromagnetic nickel powder 1. Adsorption of single components , 1995 .

[42]  K. Niihara,et al.  Morphology and structure of CuOx/CeO2 nanocomposite catalysts produced by inert gas condensation: An HREM, EFTEM, XPS, and high-energy diffraction study , 2002 .

[43]  S. Feng,et al.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[44]  A. Lehninger.  Principles of Biochemistry , 1984 .